Orally disintegrating tablet of novel salt of antiepileptic drug: Formulation strategy and evaluation
Authors:
- Ziyaur RahmanZRZiyaur Rahman
- Akhtar SiddiquiASAkhtar Siddiqui
- Mansoor A. KhanMKMansoor A. Khan
- 1 November 2013
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 85 (3) , 1300-1309
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Crystal Structures and Physicochemical Properties of Four New Lamotrigine Multicomponent FormsCrystal Growth & Design, 2013
- Improvement of the Bitter Taste of Drugs By Complexation With Cyclodextrins: applications, Evaluations and MechanismsTherapeutic Delivery, 2012
- Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other propertiesPatient Preference and Adherence, 2012
- Medication Adherence: WHO Cares?Mayo Clinic Proceedings, 2011
- Design and evaluation of taste masked chewable dispersible tablet of lamotrigine by melt granulation.International Journal of Drug Delivery, 2010
- Formulation Design and Optimization of Novel Taste Masked Mouth-Dissolving Tablets of Tramadol Having Adequate Mechanical StrengthAAPS PharmSciTech, 2009
- Factors affecting therapeutic compliance: A review from the patient’s perspectiveTherapeutics and Clinical Risk Management, 2008
- Effect of a Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein CholesterolJAMA, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- Improved Buccal Delivery of Opioid Analgesics and Antagonists with Bitterless ProdrugsPharmaceutical Research, 1988